Glucose Metabolism Disorders  >>  AZD6370  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AZD6370 / AstraZeneca
NCT00690287: A Study to Evaluate P-Glucose, Safety and Tolerability After Oral Single Dosing of AZD6370 in Type 2 Diabetic Patients

Completed
1
24
Europe
AZD6370, Placebo
AstraZeneca
Type 2 Diabetes
06/08
06/08

Download Options